Literature DB >> 21616718

Defining macrophage phenotype and function in adipose tissue.

Elise Dalmas1, Karine Clément, Michèle Guerre-Millo.   

Abstract

In obesity, chronic low-grade inflammation is thought to mediate the effects of increased adipose tissue mass on metabolic comorbidity. Of the different cell types that contribute to obesity-induced inflammation in adipose tissue, this review focuses on macrophages and their monocytes precursors. Mechanisms for monocyte recruitment to adipose tissue, and how both monocytes and macrophages are phenotypically modified in this environment in response to increasing fat mass, are considered. The versatile phenotype of adipose tissue macrophages might contribute not only to inflammatory and metabolic alterations, but could also help to maintain adipose tissue homeostasis in the setting of obesity.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21616718     DOI: 10.1016/j.it.2011.04.008

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  84 in total

Review 1.  Invariant natural killer T cells in adipose tissue: novel regulators of immune-mediated metabolic disease.

Authors:  M Rakhshandehroo; E Kalkhoven; M Boes
Journal:  Cell Mol Life Sci       Date:  2013-07-09       Impact factor: 9.261

2.  Loss of the co-repressor GPS2 sensitizes macrophage activation upon metabolic stress induced by obesity and type 2 diabetes.

Authors:  Rongrong Fan; Amine Toubal; Saioa Goñi; Karima Drareni; Zhiqiang Huang; Fawaz Alzaid; Raphaelle Ballaire; Patricia Ancel; Ning Liang; Anastasios Damdimopoulos; Isabelle Hainault; Antoine Soprani; Judith Aron-Wisnewsky; Fabienne Foufelle; Toby Lawrence; Jean-Francois Gautier; Nicolas Venteclef; Eckardt Treuter
Journal:  Nat Med       Date:  2016-06-06       Impact factor: 53.440

Review 3.  Impact of bariatric surgery on type 2 diabetes: contribution of inflammation and gut microbiome?

Authors:  Jean Debédat; Chloé Amouyal; Judith Aron-Wisnewsky; Karine Clément
Journal:  Semin Immunopathol       Date:  2019-04-25       Impact factor: 9.623

Review 4.  Macrophage-induced adipose tissue dysfunction and the preadipocyte: should I stay (and differentiate) or should I go?

Authors:  Alexander Sorisky; André S D Molgat; AnneMarie Gagnon
Journal:  Adv Nutr       Date:  2013-01-01       Impact factor: 8.701

Review 5.  Regulation of monocyte differentiation by specific signaling modules and associated transcription factor networks.

Authors:  René Huber; Daniel Pietsch; Johannes Günther; Bastian Welz; Nico Vogt; Korbinian Brand
Journal:  Cell Mol Life Sci       Date:  2013-03-24       Impact factor: 9.261

6.  Control of adipose tissue expandability in response to high fat diet by the insulin-like growth factor-binding protein-4.

Authors:  Olga Gealekman; Kunal Gurav; My Chouinard; Juerg Straubhaar; Michael Thompson; Samir Malkani; Celia Hartigan; Silvia Corvera
Journal:  J Biol Chem       Date:  2014-04-28       Impact factor: 5.157

Review 7.  Immune cells and metabolic dysfunction.

Authors:  Ashley Eheim; Dasa Medrikova; Stephan Herzig
Journal:  Semin Immunopathol       Date:  2013-11-09       Impact factor: 9.623

8.  SMRT-GPS2 corepressor pathway dysregulation coincides with obesity-linked adipocyte inflammation.

Authors:  Amine Toubal; Karine Clément; Rongrong Fan; Patricia Ancel; Veronique Pelloux; Christine Rouault; Nicolas Veyrie; Agnes Hartemann; Eckardt Treuter; Nicolas Venteclef
Journal:  J Clin Invest       Date:  2012-12-10       Impact factor: 14.808

Review 9.  Innate immune activation in obesity.

Authors:  Carey N Lumeng
Journal:  Mol Aspects Med       Date:  2012-10-13

10.  Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus.

Authors:  Andrew E Hogan; Gadintshware Gaoatswe; Lydia Lynch; Michelle A Corrigan; Conor Woods; Jean O'Connell; Donal O'Shea
Journal:  Diabetologia       Date:  2013-12-21       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.